Freenome

Freenome focuses on early cancer detection through blood tests. The company's main offerings include next-generation blood tests that utilize multiomics technology and machine learning to identify cancer in its early stages. Freenome primarily serves the healthcare sector with a focus on improving cancer screening and detection. It was founded in 2014 and is based in Brisbane, California.